fbpx

EssilorLuxottica Announces Organizational Changes

The Board of Directors of EssilorLuxottica on December 17, 2020 decided to adjust EssilorLuxottica’s governance in full respect of the equal powers principle of the business combination agreement, in order to accommodate its Executive Vice-Chairman’s desire to retire.

Mr. Sagnières leaves all his executive responsibilities at EssilorLuxottica and its subsidiaries and will remain as non-executive Vice-Chairman of the Company.

In order to preserve the equal powers principle of the business combination agreement currently in place, Leonardo Del Vecchio decided to voluntarily step back from his executive responsibilities at EssilorLuxottica and will remain non-executive Chairman of the Company.

The Board granted executive powers to Francesco Milleri and Paul du Saillant, who are appointed as Chief Executive Officer (CEO) and Deputy Chief Executive Officer (Deputy CEO) of EssilorLuxottica, respectively, until the appointment of the new Board of Directors by the 2021 annual general meeting of shareholders. Mr. du Saillant becomes Chairman and CEO of Essilor International.

The Board of Directors also decided to pay an interim dividend for the 2020 financial year of Euro 1.15 per share on December 28, 2020 (ex-date: December 23, 2020). This decision was supported by the efficacy of the measures taken to rein in costs and preserve cash and by the sound business recovery in the second half of the year.

“I want to thank Hubert for his success in turning Essilor into a world leader and helping to build EssilorLuxottica as the strong company it is today. The contributions he made during his career with the company are long-lasting”, commented Leonardo Del Vecchio.

“The incredible progress made over the last two years, and most recently under the impetus of Francesco and Paul, give me confidence that this is the right time for me to step back and transfer my executive powers to them, to facilitate a smoother governance transition. I know that this adjusted governance will further accelerate the integration of the Company and the delivery of synergies, benefitting all stakeholders, through the continued deployment of our Mission”, added Hubert Sagnières.

Click HERE for the full press release.

Other related articles

Featured Posts

Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read more
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more
Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read More
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read More
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read More
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read More
Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read more
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more
Optik VOILA January-February 2026 Lanctôt JOS980006_40-petrol-dark-gun

JOS: Titan Bold

JOS Titan Bold is a men’s frame crafted from pure titanium, featuring bevelled edges, masculine matte tones, and beta-titanium temples for durability, flexibility, and refined fit.

Learn More
EQ-based strategies for coping with depression

How to Cope with Depression: An EQ-Based Guide for Professionals

In today’s workplace, stress isn’t just common, it’s constant. Shifting expectations, increased workloads, ever-changing schedules, difficult colleagues, and the pressure to “perform with a smile” can stretch even the highest-achieving professionals thin.

Read more
ClearVision logo

ClearVision Optical Names 2025 Fred Friedfeld Scholarship Recipient

ClearVision Optical recognizes Monica Van Duyne as the 2025 Fred Friedfeld Memorial Scholarship recipient, supporting optometry education.

Read more
Vision Expo new logo

Vision Expo 2026 Marks 40 Years with Unified Annual Event in Orlando

Vision Expo returns to Orlando in March 2026 as a unified annual event, featuring accredited education, new product launches and a 40th anniversary celebration.

Read more
CRO logo image for Research Updates in Optik magazine

Role of B Vitamins in Preventing the Development and Progression of Age-Related Macular Degeneration

A 2025 review highlights evidence linking vitamins B6, B9 and B12 to reduced risk and slower progression of age-related macular degeneration, with AREDS3 set to explore added benefit.

Read more